Press Releases

Zero Gravity Solutions, Inc. Issued Patent for its Commercial Product for Agriculture, BAM-FX™, by the United States Patent and Trademark Office

BOCA RATON, Fla.— (February 24, 2016),– Zero Gravity Solutions, Inc.'s (ZGSI or the Company) (Pink Sheets: ZGSI), an agricultural biotechnology public company commercializing its technology derived from and designed for Space with significant applications on Earth, has previously announced the notification of approval for BAM-FX by the United States Patent and Trademark Office (USPTO). The Company today was issued U.S. Patent No. 9,266,785 for BAM-FX.

BAM-FX is the first formulation of a family of BAM (Bio Available Minerals) products designed to increase crop yields and quality while also addressing crop plant mineral deficiencies and the stress related challenges facing agriculture worldwide. Major problems facing agriculture include population growth and the hidden hunger of humans on our planet known globally as crop mineral deficiencies in (zinc, selenium, iron and iodine), and coping with the now common weather events resulting in excessive heat and drought, frost and wind damage. Furthermore, soil degradation caused by excessive use of chemicals/fertilizers and subsequent damage to aquifers and water bodies caused by run-off can all be potentially mitigated by adopting the use of Precision Agricultural micronutrient products such as BAM-FX that help increase the efficiencies of fertilizer use.

“These agricultural problems can be addressed through precision farming techniques along with the use of new technology innovations, such as BAM-FX. BAM-FX provides the means to deliver bioavailable forms of micronutrients, such as copper and zinc in precise ratios through our technology, which allows these micronutrients to actually enter into the plants cells. This results in visibly better growth, enhanced yields with better food quality and other crop benefits including observed plant stress tolerance,” stated Glenn Stinebaugh, ZGSI’s President and Chief Executive Officer.

Zero Gravity Solutions, Inc. Signs Space Act Agreement with
NASA Ames Research Center

BOCA RATON, Fla.— (January 14, 2016),– Zero Gravity Solutions, Inc.'s (ZGSI or the Company) (Pink Sheets: ZGSI), an agricultural biotechnology public company commercializing its technology derived from and designed for Space with significant applications on Earth, announced today that it has signed a Reimbursable Space Act Agreement (the Space Act Agreement) with NASA Ames Research Center (ARC) to evaluate ZGSI’s nutrient delivery system for commercial agriculture. Pursuant to the Space Act Agreement, the Company shall provide certain funding for research, but shall own the resulting intellectual property. The focus of this partnership is the development of new agricultural technologies and products. The primary objectives of the Space Act Agreement are as follows:

  • To establish a scientific basis for action of ZGSI products;
  • To quantify the impact of ZGSI products on plant growth and productivity;
  • To evaluate and test the impact of ZGSI products on yield physiology of selected crops important to commercial agriculture; and
  • To evaluate and test the potential utility of ZGSI products to NASA space biology and life support applications.


Further, ZGSI shall utilize the unique, ground-based, controlled environment facilities and research personnel at ARC to address a series of science-based inquires relevant to both ZGSI and NASA. The initial product to be studied is the Company’s BAM-FX™ (Bioavailable Minerals – Formula X), an ionic nutrient delivery formulation designed to effectively deliver bioavailable forms of important nutrients to support plant growth. Field testing conducted by ZGSI’s wholly owned subsidiary BAM Agricultural Solutions over the last two years in multiple crop types have indicated increases in overall yield, health and productivity compared to standard farming practices.

Contact Information

Zero Gravity Solutions, Inc.
190 NW Spanish River Blvd.
Boca Raton, FL 33431
USA

Telephone: +1 561-416-0400
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.